Adverse cutaneous reactions to antidepressants

Area of Science:

• Dermatology
• Psychiatry
• Pharmacology

Background:

• Antidepressants are widely prescribed, and psychotropic medications may have higher rates of adverse cutaneous drug reactions (ACDRs).
• While most ACDRs are benign, serious and life-threatening reactions can occur rarely.
• Diagnosis of ACDRs is primarily based on patient history.

Purpose of the Study:

• To review the occurrence, risk factors, and management of antidepressant-associated adverse cutaneous drug reactions.
• To inform clinicians about potential serious skin reactions to antidepressants.
• To guide management decisions balancing psychiatric relapse risk with ACDR management.

Main Methods:

• Review of literature on antidepressant-induced adverse cutaneous drug reactions.
• Analysis of patient history as the primary diagnostic tool.
• Discussion of risk factors and clinical presentation of ACDRs.

Main Results:

• Certain patient characteristics increase ACDR risk: female gender, older age, African-American ethnicity, polypharmacy, and serious illness.
• Discontinuation of the offending antidepressant and substitution with a drug from another class is recommended for outpatient reactions.
• Symptomatic treatment is advised for uncomplicated ACDRs; dermatology consultation is recommended for severe reactions.

Conclusions:

• Clinicians must be aware of common and serious antidepressant-related ACDRs to prevent recurrence.
• Management involves risk-benefit analysis, weighing ACDR risks against psychiatric relapse.
• Understanding risk factors and appropriate management strategies is crucial for patient care.